journal article·2025-09-19Open access

Bio-Functional Nanomaterials for Enhanced Lung Cancer Therapy: The Synergistic Roles of Vitamins D and K

Andreea Crintea, Camelia Munteanu, Tamás Ilyés, Ciprian N. Silaghi, Alexandra M. Crăciun

Abstract

Lung cancer remains a leading cause of cancer-related mortality worldwide, requiring the development of innovative and effective therapeutic strategies. Bio-functional nanomaterials, due to their unique physicochemical properties, offer a versatile platform for targeted drug delivery, controlled release, and multimodal therapies, thereby enhancing efficacy and reducing the systemic toxicity of conventional treatments. Independently, both vitamin D and vitamin K have demonstrated significant anti-cancer properties, including inhibition of proliferation, induction of apoptosis, modulation of angiogenesis, and attenuation of metastatic potential in various cancer cell lines and in vivo models. However, their clinical application is often limited by poor bioavailability, rapid metabolism, and potential for off-target effects. Specifically, by enhancing the solubility, stability, and targeted accumulation of fat-soluble vitamins D and K within tumoral tissues for improved lung cancer therapy, this review emphasizes the novel and cooperative role of bio-functional nanomaterials in overcoming these limitations. Future studies should focus on the logical development of sophisticated nanomaterial carriers for optimal co-delivery plans and thorough in vivo validation, aiming to convert these encouraging preclinical results into successful clinical treatments for patients with lung cancer.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Peptidase Inhibition and Analysis · Nanoparticle-Based Drug Delivery · Vitamin D Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Molecular Sciences, University of Medicine and Pharmacy “Iuliu Hațieganu”, 400349 Cluj-Napoca, Romania

Biology Section, University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca, 400372 Cluj-Napoca, Romania

References (100+)

Show source-provided references
1. Non-Small Cell Lung Cancer: Current Treatment and Future Advances10.21037/tlcr.2016.06.07 ↗
2. Vitamin D and Lung Cancer Risk: A Comprehensive Review and Meta-Analysis10.1159/000374072 ↗
3. Henn, M., Martin-Gorgojo, V., and Martin-Moreno, J.M. (2022). Vitamin D in Cancer Prevention: Gaps in Current Knowledge and Room for Hope. Nutrients, 14.10.3390/nu14214512 ↗
4. Vitamin D Metabolism and Guidelines for Vitamin D Supplementation10.33176/AACB-20-00006 ↗
5. New Insights on Vitamin K Biology with Relevance to Cancer10.1016/j.molmed.2022.07.002 ↗
6. Munteanu, C., Mârza, S.M., and Papuc, I. (2024). The Immunomodulatory Effects of Vitamins in Cancer. Front. Immunol., 15.10.3389/fimmu.2024.1464329 ↗
7. Global Burden and Trends of Lung Cancer Incidence and Mortality10.1097/CM9.0000000000002529 ↗
8. New Approaches and Procedures for Cancer Treatment: Current Perspectives10.1177/20503121211034366 ↗
9. Advancements and Limitations in Traditional Anti-Cancer Therapies: A Comprehensive Review of Surgery, Chemotherapy, Radiation Therapy, and Hormonal Therapy10.1007/s12672-025-02198-8 ↗
10. Targeting Cancer with Precision: Strategical Insights into TCR-Engineered T Cell Therapies10.7150/thno.104594 ↗
11. Ovcharenko, D., Mukhin, D., and Ovcharenko, G. (2024). Alternative Cancer Therapeutics: Unpatentable Compounds and Their Potential in Oncology. Pharmaceutics, 16.10.3390/pharmaceutics16091237 ↗
12. Progressing Nanotechnology to Improve Targeted Cancer Treatment: Overcoming Hurdles in Its Clinical Implementation10.1186/s12943-023-01865-0 ↗
13. Nanomedicine: How Nanomaterials Are Transforming Drug Delivery, Bio-Imaging, and Diagnosis10.1016/j.nxnano.2024.100129 ↗
14. Advances in Nanoparticles in Targeted Drug Delivery—A Review10.1016/j.rsurfi.2025.100529 ↗
15. Integrating Natural Compounds and Nanoparticle-based Drug Delivery Systems: A Novel Strategy for Enhanced Efficacy and Selectivity in Cancer Therapy10.1002/cam4.7010 ↗
16. Talib, W.H., Ahmed Jum’AH, D.A., Attallah, Z.S., Jallad, M.S., Al Kury, L.T., Hadi, R.W., and Mahmod, A.I. (2024). Role of Vitamins A, C, D, E in Cancer Prevention and Therapy: Therapeutic Potentials and Mechanisms of Action. Front. Nutr., 10.10.3389/fnut.2023.1281879 ↗
17. Pharmacokinetics of Vitamin Dosage Forms: A Complete Overview10.1002/fsn3.3787 ↗
18. Cancer Nanomedicine: From Targeted Delivery to Combination Therapy10.1016/j.molmed.2015.01.001 ↗
19. Precision Nanomedicine: Navigating the Tumor Microenvironment for Enhanced Cancer Immunotherapy and Targeted Drug Delivery10.1186/s12943-025-02357-z ↗
20. Islam, W., Niidome, T., and Sawa, T. (2022). Enhanced Permeability and Retention Effect as a Ubiquitous and Epoch-Making Phenomenon for the Selective Drug Targeting of Solid Tumors. J. Pers. Med., 12.10.3390/jpm12121964 ↗
21. Wu, J. (2021). The Enhanced Permeability and Retention (EPR) Effect: The Significance of the Concept and Methods to Enhance Its Application. J. Pers. Med., 11.10.3390/jpm11080771 ↗
22. Yao, Y., Zhou, Y., Liu, L., Xu, Y., Chen, Q., Wang, Y., Wu, S., Deng, Y., Zhang, J., and Shao, A. (2020). Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance. Front. Mol. Biosci., 7.10.3389/fmolb.2020.00193 ↗
23. Recent Developments in Nanocarriers for Cancer Chemotherapy10.1016/j.onano.2022.100080 ↗
24. Functional Ligands for Improving Anticancer Drug Therapy: Current Status and Applications to Drug Delivery Systems10.1080/10717544.2022.2089296 ↗
25. Toward a Magic or Imaginary Bullet? Ligands for Drug Targeting to Cancer Cells: Principles, Hopes, and Challenges
26. Cancer Nanotechnology: The Impact of Passive and Active Targeting in the Era of Modern Cancer Biology10.1016/j.addr.2013.11.009 ↗
27. Advances in Drug Delivery Systems, Challenges and Future Directions10.1016/j.heliyon.2023.e17488 ↗
28. Nanogels: An Overview of Properties, Biomedical Applications and Obstacles to Clinical Translation10.1016/j.jconrel.2015.11.009 ↗
29. Hajebi, S., Chamanara, M., Nasiri, S.S., Ghasri, M., Mouraki, A., Heidari, R., and Nourmohammadi, A. (2024). Advances in Stimuli-Responsive Gold Nanorods for Drug-Delivery and Targeted Therapy Systems. Biomed. Pharmacother., 180.10.1016/j.biopha.2024.117493 ↗
30. Torres, J., Valenzuela Oses, J.K., Rabasco-Álvarez, A.M., González-Rodríguez, M.L., and García, M.C. (2025). Innovations in Cancer Therapy: Endogenous Stimuli-Responsive Liposomes as Advanced Nanocarriers. Pharmaceutics, 17.10.3390/pharmaceutics17020245 ↗
31. Nanoparticles in Cancer Theragnostic and Drug Delivery: A Comprehensive Review10.1016/j.lfs.2024.122899 ↗
32. Theranostics and Artificial Intelligence: New Frontiers in Personalized Medicine10.7150/thno.94788 ↗
33. Roma-Rodrigues, C., Rivas-García, L., Baptista, P.V., and Fernandes, A.R. (2020). Gene Therapy in Cancer Treatment: Why Go Nano?. Pharmaceutics, 12.10.3390/pharmaceutics12030233 ↗
34. RGD Peptide in Cancer Targeting: Benefits, Challenges, Solutions, and Possible Integrin–RGD Interactions10.1002/cam4.6800 ↗
35. Nano-Drug Delivery: Is the Enhanced Permeability and Retention (EPR) Effect Sufficient for Curing Cancer?10.1021/acs.bioconjchem.6b00437 ↗
36. Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy10.7150/thno.3463 ↗
37. Tumor Targeting via EPR: Strategies to Enhance Patient Responses10.1016/j.addr.2018.07.007 ↗
38. Nanoparticle-Based Drug Delivery Systems Targeting Cancer Cell Surfaces10.1039/D3RA02969G ↗
39. Subhan, M.A., Yalamarty, S.S.K., Filipczak, N., Parveen, F., and Torchilin, V.P. (2021). Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment. J. Pers. Med., 11.10.3390/jpm11060571 ↗
40. Serial Stimuli-Responsive Theranostic Nanomaterials for Cancer Therapy and Imaging10.1016/j.ccr.2025.216897 ↗
41. Engineering Strategies of Sequential Drug Delivery Systems for Combination Tumor Immunotherapy10.1016/j.apsb.2025.05.039 ↗
42. Smart Drug Delivery Systems for Precise Cancer Therapy10.1016/j.apsb.2022.08.013 ↗
43. Shah, S., and D’Souza, G.G.M. (2025). Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis. Cells, 14.10.3390/cells14100732 ↗
44. Enabling Technologies for Personalized and Precision Medicine10.1016/j.tibtech.2019.12.021 ↗
45. Biologics, Theranostics, and Personalized Medicine in Drug Delivery Systems10.1016/j.phrs.2024.107086 ↗
46. Basumallik, N., and Agarwal, M. (2025). Small Cell Lung Cancer. StatPearls, StatPearls Publishing.
47. Babar, Q., Saeed, A., Tabish, T.A., Sarwar, M., and Thorat, N.D. (2023). Targeting the Tumor Microenvironment: Potential Strategy for Cancer Therapeutics. Biochim. Biophys. Acta Mol. Basis Dis., 1869.10.1016/j.bbadis.2023.166746 ↗
48. Yusuf, A., Almotairy, A.R.Z., Henidi, H., Alshehri, O.Y., and Aldughaim, M.S. (2023). Nanoparticles as Drug Delivery Systems: A Review of the Implication of Nanoparticles’ Physicochemical Properties on Responses in Biological Systems. Polymers, 15.10.3390/polym15071596 ↗
49. Nanoparticle-Based Materials in Anticancer Drug Delivery: Current and Future Prospects10.1016/j.heliyon.2023.e21227 ↗
50. The Role of Nanoparticles and Nanomaterials in Cancer Diagnosis and Treatment: A Comprehensive Review
51. Liposomes: Structure, Composition, Types, and Clinical Applications10.1016/j.heliyon.2022.e09394 ↗
52. Ghadami, S., and Dellinger, K. (2023). The Lipid Composition of Extracellular Vesicles: Applications in Diagnostics and Therapeutic Delivery. Front. Mol. Biosci., 10.10.3389/fmolb.2023.1198044 ↗
53. A Review on Phospholipids and Their Main Applications in Drug Delivery Systems
54. Liu, P., Chen, G., and Zhang, J. (2022). A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives. Molecules, 27.10.3390/molecules27041372 ↗
55. Innovations in Breaking Barriers: Liposomes as Near-Perfect Drug Carriers in Ischemic Stroke Therapy10.2147/IJN.S462194 ↗
56. Liposome-Based Antibacterial Delivery: An Emergent Approach to Combat Bacterial Infections10.1021/acsomega.3c04893 ↗
57. PEGylation in Pharmaceutical Development: Current Status and Emerging Trends in Macromolecular and Immunotherapeutic Drugs
58. Accelerated Blood Clearance of PEGylated Liposomes upon Repeated Injections: Effect of Doxorubicin-Encapsulation and High-Dose First Injection10.1016/j.jconrel.2006.08.017 ↗
59. Influence of PEG Coating on the Biodistribution and Tumor Accumulation of pH-Sensitive Liposomes10.1007/s13346-018-0583-8 ↗
60. EGF Receptor-Targeted Nanocarriers for Enhanced Cancer Treatment10.2217/nnm.12.160 ↗
61. George, M., Boukherroub, R., Sanyal, A., and Szunerits, S. (2025). Treatment of Lung Diseases via Nanoparticles and Nanorobots: Are These Viable Alternatives to Overcome Current Treatments?. Mater. Today Bio., 31.10.1016/j.mtbio.2025.101616 ↗
62. Lin, Y.-W., Su, H.-C., Raj, E.N., Liu, K.-K., Chang, C.-J., Hsu, T.-C., Cheng, P.-Y., Wang, R.-H., Lai, Y.-H., and Chen, C.-H. (2022). Targeting EGFR and Monitoring Tumorigenesis of Human Lung Cancer Cells In Vitro and In Vivo Using Nanodiamond-Conjugated Specific EGFR Antibody. Pharmaceutics, 15.10.3390/pharmaceutics15010111 ↗
63. Recent Advances and Clinical Translation of Liposomal Delivery Systems in Cancer Therapy10.1016/j.ejps.2023.106688 ↗
64. Agrawal, S.S., Baliga, V., and Londhe, V.Y. (2025). Liposomal Formulations: A Recent Update. Pharmaceutics, 17.10.3390/pharmaceutics17010036 ↗
65. Lombardo, D., and Kiselev, M.A. (2022). Methods of Liposomes Preparation: Formation and Control Factors of Versatile Nanocarriers for Biomedical and Nanomedicine Application. Pharmaceutics, 14.10.3390/pharmaceutics14030543 ↗
66. Basak, S., and Das, T.K. (2025). Liposome-Based Drug Delivery Systems: From Laboratory Research to Industrial Production—Instruments and Challenges. ChemEngineering, 9.10.3390/chemengineering9030056 ↗
67. Elmowafy, M., Shalaby, K., Elkomy, M.H., Alsaidan, O.A., Gomaa, H.A.M., Abdelgawad, M.A., and Mostafa, E.M. (2023). Polymeric Nanoparticles for Delivery of Natural Bioactive Agents: Recent Advances and Challenges. Polymers, 15.10.3390/polym15051123 ↗
68. Zielińska, A., Carreiró, F., Oliveira, A.M., Neves, A., Pires, B., Venkatesh, D.N., Durazzo, A., Lucarini, M., Eder, P., and Silva, A.M. (2020). Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology. Molecules, 25.10.3390/molecules25163731 ↗
69. Eltaib, L. (2025). Polymeric Nanoparticles in Targeted Drug Delivery: Unveiling the Impact of Polymer Characterization and Fabrication. Polymers, 17.10.3390/polym17070833 ↗
70. Polymeric Nanoparticles for Drug Delivery10.1021/acs.chemrev.3c00705 ↗
71. Application of Nanomaterials in Precision Treatment of Lung Cancer10.1016/j.isci.2024.111704 ↗
72. Gagliardi, A., Giuliano, E., Venkateswararao, E., Fresta, M., Bulotta, S., Awasthi, V., and Cosco, D. (2021). Biodegradable Polymeric Nanoparticles for Drug Delivery to Solid Tumors. Front. Pharmacol., 12.10.3389/fphar.2021.601626 ↗
73. Xia, W., Tao, Z., Zhu, B., Zhang, W., Liu, C., Chen, S., and Song, M. (2021). Targeted Delivery of Drugs and Genes Using Polymer Nanocarriers for Cancer Therapy. Int. J. Mol. Sci., 22.10.3390/ijms22179118 ↗
74. Polymeric Drug Delivery Systems by Additive Manufacturing10.1016/j.addr.2021.03.022 ↗
75. Application of Targeted Drug Delivery by Cell Membrane-Based Biomimetic Nanoparticles for Inflammatory Diseases and Cancers10.1186/s40001-024-02124-8 ↗
76. Adeniji, T.M., Haroon, N., and Stine, K.J. (2025). Applications of Nanomaterial Coatings in Solid-Phase Microextraction (SPME). Processes, 13.10.3390/pr13010244 ↗
77. Alhalili, Z. (2023). Metal Oxides Nanoparticles: General Structural Description, Chemical, Physical, and Biological Synthesis Methods, Role in Pesticides and Heavy Metal Removal through Wastewater Treatment. Molecules, 28.10.3390/molecules28073086 ↗
78. Wang, J., Wang, H., Zou, F., Gu, J., Deng, S., Cao, Y., and Cai, K. (2025). The Role of Inorganic Nanomaterials in Overcoming Challenges in Colorectal Cancer Diagnosis and Therapy. Pharmaceutics, 17.10.3390/pharmaceutics17040409 ↗
79. Understanding Gold Nanoparticles and Their Attributes in Ovarian Cancer Therapy10.1186/s12943-025-02280-3 ↗
80. AlQurashi, D.M., AlQurashi, T.F., Alam, R.I., Shaikh, S., and Tarkistani, M.A.M. (2025). Advanced Nanoparticles in Combating Antibiotic Resistance: Current Innovations and Future Directions. J. Nanotheranostics, 6.10.3390/jnt6020009 ↗
81. Cheng, X., Xie, Q., and Sun, Y. (2023). Advances in Nanomaterial-Based Targeted Drug Delivery Systems. Front. Bioeng. Biotechnol., 11.10.3389/fbioe.2023.1177151 ↗
82. Nanoparticles for Drug Delivery: Insight into in Vitro and in Vivo Drug Release from Nanomedicines10.1016/j.ntm.2025.100083 ↗
83. Negut, I., and Bita, B. (2023). Polymeric Micellar Systems—A Special Emphasis on “Smart” Drug Delivery. Pharmaceutics, 15.10.3390/pharmaceutics15030976 ↗
84. Figueiras, A., Domingues, C., Jarak, I., Santos, A.I., Parra, A., Pais, A., Alvarez-Lorenzo, C., Concheiro, A., Kabanov, A., and Cabral, H. (2022). New Advances in Biomedical Application of Polymeric Micelles. Pharmaceutics, 14.10.3390/pharmaceutics14081700 ↗
85. Wang, Q., Atluri, K., Tiwari, A.K., and Babu, R.J. (2023). Exploring the Application of Micellar Drug Delivery Systems in Cancer Nanomedicine. Pharmaceuticals, 16.10.3390/ph16030433 ↗
86. Controlling Lipid Micelle Stability Using Oligonucleotide Headgroups10.1021/ja512012m ↗
87. Strategies to Improve Micelle Stability for Drug Delivery10.1007/s12274-018-2152-3 ↗
88. Polymeric Micelles and Alternative Nanonized Delivery Vehicles for Poorly Soluble Drugs10.1016/j.ijpharm.2012.08.042 ↗
89. Feingold, K.R., Ahmed, S.F., Anawalt, B., Blackman, M.R., Boyce, A., Chrousos, G., Corpas, E., de Herder, W.W., and Dhatariya, K. (2000). Vitamin D: Production, Metabolism, and Mechanism of Action. Endotext, MDText.com, Inc.
90. Vitamin D: Dosing, Levels, Form, and Route of Administration: Does One Approach Fit All?10.1007/s11154-021-09693-7 ↗
91. El-Sharkawy, A., and Malki, A. (2020). Vitamin D Signaling in Inflammation and Cancer: Molecular Mechanisms and Therapeutic Implications. Molecules, 25.10.3390/molecules25143219 ↗
92. Nuclear Vitamin D Receptor Expression Is Associated with Improved Survival in Non-Small Cell Lung Cancer10.1016/j.jsbmb.2010.10.002 ↗
93. Vitamin D Receptor Signaling and Cancer10.1016/j.ecl.2017.07.007 ↗
94. Mechanistic Effects of Calcitriol in Cancer Biology10.3390/nu7065020 ↗
95. Mustafa, M., Ahmad, R., Tantry, I.Q., Ahmad, W., Siddiqui, S., Alam, M., Abbas, K., Hassan, M.I., and Habib, S. (2024). Apoptosis: A Comprehensive Overview of Signaling Pathways, Morphological Changes, and Physiological Significance and Therapeutic Implications. Cells, 13.10.3390/cells13221838 ↗
96. Qian, S., Wei, Z., Yang, W., Huang, J., Yang, Y., and Wang, J. (2022). The Role of BCL-2 Family Proteins in Regulating Apoptosis and Cancer Therapy. Front. Oncol., 12.10.3389/fonc.2022.985363 ↗
97. Angiogenesis and Targeted Therapy in the Tumour Microenvironment: From Basic to Clinical Practice10.1002/ctm2.70313 ↗
98. Tumor Angiogenesis: Causes, Consequences, Challenges and Opportunities10.1007/s00018-019-03351-7 ↗
99. The Anti-Cancer and Anti-Inflammatory Actions of 1,25(OH)2D310.1016/j.beem.2011.05.001 ↗
100. The Role of Vitamin D in Cancer Prevention and Treatment10.1016/j.ecl.2010.02.011 ↗